The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

Carbonneau, Mélissa, M. Gagné, Laurence, Lalonde, Marie-Eve, Germain, Marie-Anne, Motorina, Alena, Guiot, Marie-Christine, Secco, Blandine, Vincent, Emma E. +10 more·2016·Nature Communications
DOI 10.1038/ncomms12700

Cited by (180)

Items 101–180 of 180

  1. G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer
    Magdalena Dragan, Mai-Uyen Nguyen, Stephania Guzman, Cameron Glenn-Franklin Goertzen, Muriel Brackstone, Waljit Singh Dhillo, Paul Bech, Sophie A. Clarke, Ali Abbara, Alan B. Tuck et al. · 2020 · Cell Death and Disease
  2. Heme promotes transcriptional and demethylase activities of Gis1, a member of the histone demethylase JMJD2/KDM4 family
    Sneha Lal, Jonathan M. Comer, Purna Chaitanya Konduri, Ajit N. Shah, Tianyuan Wang, Anthony Lewis, Grant M. Shoffner, Feng Guo, Zhang Li · 2017 · Nucleic Acids Research
  3. Overexpression of mTOR and p(240–244)S6 in IDH1 Wild-Type Human Glioblastomas Is Predictive of Low Survival
    Luís Eduardo Machado, Arthur William Alvarenga, Fernanda Ferreira da Silva, Martín Roffé, María Dirlei Begnami, Luis Fernando Bleggi Torres, Isabela Werneck da Cunha, Vilma Regina Martins, Glaucia N. M. Hajj · 2018 · Journal of Histochemistry & Cytochemistry
  4. An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors
    Sara Verdura, Elisabet Cuyàs, Jesús Lozano‐Sánchez, Cristian Bastidas-Velez, Laura Llorach-Parés, Salvador Fernández‐Arroyo, Anna Hernández‐Aguilera, Jorge Joven, Alfons Nonell‐Canals, Joaquim Bosch‐Barrera et al. · 2018 · Carcinogenesis
  5. Spatiotemporal Heterogeneity of Tumor Glucose Metabolism Reprogramming: From Single-Cell Mechanisms to Precision Interventions
    Xiaoxue Chai, Qian Tao, Lili Li · 2025 · International Journal of Molecular Sciences
  6. A helminth enzyme subverts macrophage-mediated immunity by epigenetic targeting of prostaglandin synthesis
    Sina Bohnacker, Fiona D. R. Henkel, Franziska Hartung, Arie Geerlof, Sandra Riemer, Ulrich Fabien Prodjinotho, Eya Ben Salah, André Mourão, Stefan Bohn, Tarvi Teder et al. · 2024 · Science Immunology
  7. MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations
    Sisheng Liu, Jinpeng Liu, Yanqi Xie, Tingting Zhai, Eugene W. Hinderer, Arnold J. Stromberg, Nathan L. Vanderford, Jill Kolesar, Hunter Moseley, Li Chen et al. · 2020 · Bioinformatics
  8. Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer
    Jie Hao, Ziyi Huang, Siyue Zhang, Kefan Song, Juncheng Wang, Chao Gao, Zhiqing Fang, Ning Zhang · 2024 · Pharmacological Research
  9. Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling
    Laurence M. Gagné, Nadine Morin, Noémie Lavoie, Nicolas Bisson, Jean-Philippe Lambert, Frédérick A. Mallette, Marc-Étienne Huot · 2021 · Journal of Biological Chemistry
  10. Targeting epigenetic mechanisms to overcome venetoclax resistance
    Gabriel Prado, Charlotte Leonie Kaestner, Jonathan D. Licht, Richard Lynn Bennett · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  11. The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
    Vivek Hariharan, Travis T. Denton, Sarah Paraszcszak, Kyle McEvoy, Thomas M. Jeitner, Boris F. Krasnikov, Arthur J.L. Cooper · 2017 · Biology
  12. Anaplastic gliomas in adults: an update
    Cristina Izquierdo, Bastien Joubert, François Ducray · 2017 · Current Opinion in Oncology
  13. Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
    Yosuke Kitagawa, Ami Kobayashi, Daniel P. Cahill, Hiroaki Wakimoto, Shota Tanaka · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  14. Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells
    Jose A. Sandoval, Alexey A. Tomilov, Sandipan Datta, Sonia A. Allen, Robert T. OʼDonnell, Thomas K. Sears, Kevin Woolard, Dmytro Kovalskyy, James M. Angelastro, Gino A. Cortopassi · 2020 · Pharmaceuticals
  15. Current development and future perspective of IDH1 inhibitors in cholangiocarcinoma
    Jorge Adeva · 2021 · Liver Cancer International
  16. Sexually dimorphic acetyl‐ CoA biosynthesis and utilization in response to drought and exogenous acetic acid
    Linchao Xia, Menghan Li, Yao Chen, Yujie Dai, Huanhuan Li, Sheng Zhang · 2024 · The Plant Journal
  17. IDH1 mutation activates mTOR signaling pathway, promotes cell proliferation and invasion in glioma cells
    Timuçin Avşar, Tansu Bilge Kose, Muhammed Deniz Oksal, Gizem Turan, Türker Kılıç · 2022 · Molecular Biology Reports
  18. From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
    Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Agostino Steffan, Giuseppe Corona · 2021 · International Journal of Molecular Sciences
  19. The Crucial Roles of Intermediate Metabolites in Cancer
    Sisi Huang, Zhiqin Wang, Liang Zhao · 2021 · Cancer Management and Research
  20. A Förster resonance energy transfer-based d-2-hydroxyglutarate biosensor
    Dan Xiao, Xianzhi Xu, Kaiyu Gao, Mengjiao Wang, Wen Zhang, Chuanjuan Lü, Xia Wang, Qian Wang, Ping Xu, Cuiqing Ma et al. · 2023 · Sensors and Actuators B Chemical
  21. Molecular classification of adult gliomas: recent advances and future perspectives
    Marc Barritault, David Meyronet, François Ducray · 2018 · Current Opinion in Oncology
  22. Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
    Tong Zhang, Ping Gao, Linchong Sun · 2025 · MedComm – Oncology
  23. Metabolic reprogramming-driven resistance to multi-kinase inhibitors in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities
    Junxin Li, Yu Huang, Jiawei Li, Min Shi, Yi Xiao, Fei Du, Gongli Hu · 2026 · Molecular Cancer
  24. Development of diagnostic model of lung cancer based on multiple tumor markers and data mining
    Zhaoxian Wang, Feifei Feng, Xiaoshan Zhou, Liju Duan, Jing Wang, Yongjun Wu, Na Wang · 2017 · Oncotarget
  25. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster
    Ashish Kumar Mishra, Siddharth Singh, Sruthilaya Dayanandan, Smaran Banerjee, Soumyadeep Chakraborty, Akshita Baiju Gopal, Supriya Samal, Indrajit Poirah, Debashish Chakraborty, Asima Bhattacharyya · 2022 · Cytokine
  26. Alternative oxidase blunts pseudohypoxia and photoreceptor degeneration due to RPE mitochondrial dysfunction
    Ming Chen, Yekai Wang, Roopa Dalal, Jianhai Du, Douglas Vollrath · 2024 · Proceedings of the National Academy of Sciences
  27. Heme, A Metabolic Sensor, Directly Regulates the Activity of the KDM4 Histone Demethylase Family and Their Interactions with Partner Proteins
    Purna Chaitanya Konduri, Tianyuan Wang, Narges Salamat, Zhang Li · 2020 · Cells
  28. Function of Deptor and its roles in hematological malignancies
    Mario Morales-Martínez, Alan K. Lichtenstein, Mario I. Vega · 2021 · Aging
  29. The hepatocellular carcinoma (HCC) stage carcinogenesis is associated with genomic instability features
    Karthik Balakrishnan · 2023 · Human Gene
  30. Identification of mIDH1 R132C/S280F Inhibitors from Natural Products by Integrated Molecular Docking, Pharmacophore Modeling and Molecular Dynamics Simulations
    Weitong Zhang, Hailong Bai, Yifan Wang, Xiaorui Wang, Ruyi Jin, Hui Guo, Huanling Lai, Yuping Tang, Yuwei Wang · 2024 · Pharmaceuticals
  31. R -2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity
    Florence Couteau, Laurence M. Gagné, Karine Boulay, Philippe Rousseau, Mélissa Carbonneau, Mary E. McQuaid, Jyoti Nanda Sharma, Christina Sawchyn, Erlinda Fernández, Dagmar Glatz et al. · 2025 · Nucleic Acids Research
  32. Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation
    Mario I. Vega, Yu Chen, Yijiang Shi, Joseph Gera, Alan K. Lichtenstein · 2022 · Journal of Biological Chemistry
  33. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas
    Juliete Nathali Scholl, Augusto Ferreira Weber, Camila Kehl Dias, Vinícius Pierdoná, Lucas Kich Grün, Diego Zambonin, Eduardo Anzolin, Wanderson Willian Dos Santos Dias, Willian Pegoraro Kus, Florencia María Barbé‐Tuana et al. · 2023 · Purinergic Signalling
  34. Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity
    Kate M. Saville, Rasha Q. Al‐Rahahleh, Aisha H. Siddiqui, Morgan E. Andrews, Wynand Paul Roos, Christopher A. Koczor, Joel Andrews, Faisal Hayat, Marie E. Migaud, Robert William Sobol · 2024 · DNA repair
  35. idh-1 neomorphic mutation confers sensitivity to vitamin B12 in Caenorhabditis elegans
    Olga Ponomarova, Alyxandra N. Starbard, Alexandra C. Belfi, Amanda V Anderson, Meera V. Sundaram, Albertha J.M. Walhout · 2024 · Life Science Alliance
  36. Early seizure freedom with [ 18 F ]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report
    Roberta Rudà, Francesco Bruno, Alessia Pellerino, Edoardo Pronello, Michela Zotta, Silvia Daniela Morbelli · 2025 · Epilepsia
  37. Vitamin C down-regulates the H3K9me3-dependent heterochromatin in buffalo fibroblasts via PI3K/PDK1/SGK1/KDM4A signal axis
    Jinling Wang, Lei Wang, Zhiqiang Wang, Meiyun Lv, Jiayuan Fu, Yunchuan Zhang, Peng Qiu, Deshun Shi, Chan Luo · 2023 · Theriogenology
  38. Discovery of chirally dependent protein modifications by D- and L-2-hydroxyglutarates
    Zheng Zhang, Yi-Kai Liu, Zhuojun Luo, Meng‐Ju Wu, Claudia N. Evans, Zihan Qu, Fanglei Xue, Zhijian Wang, Lia Stanciu, Zhong‐Yin Zhang et al. · 2026 · Nature Chemistry
  39. Diagnostics of IDH1/2 Mutations in Intracranial Chondroid Tumors: Comparison of Molecular Genetic Methods and Immunohistochemistry
    V. O. Varachev, A. P. Shekhtman, D. A. Guskov, Дмитрий Викторович Рогожин, Alexander S. Zasedatelev, Tatiana V. Nasedkina · 2024 · Diagnostics
  40. Selection of Stable Reference Genes for Gene Expression Studies in Activated and Non-Activated PBMCs Under Normoxic and Hypoxic Conditions
    Artur Wardaszka, Anna Smolarska, Piotr Bednarczyk, Joanna Katarzyna Bujak · 2025 · International Journal of Molecular Sciences
  41. kdm4aa is required for reproduction and development of zebrafish
    Lijie Han, Juntao Luo, Songya Qu, Xueling Shi, Junfang Zhang, Bingshe Han · 2022 · Aquaculture and Fisheries
  42. Systems Biology of Aging, Metabolism, and Mitochondria
    Miguel Antonio Aon, Sonia C. Cortassa · 2026 · Annual Review of Biophysics
  43. Immunometabolic Regulation of Anti-Tumor T-Cell Responses by the Oncometabolite D-2-Hydroxyglutarate
    Martin Böttcher, Dimitrios Mougiakakos · 2019 · Immunometabolism
  44. Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma
    Priya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, Olivia Gugliemini, Huimin Geng, Vishesh Sarin, Amrik S. Kang, Audrey Kishishita, Sham Rampersaud, Letitia Sarah et al. · 2024 · Blood Neoplasia
  45. Discovery of Aloperine as a Potential Antineoplastic Agent for Cholangiocarcinoma Harboring Mutant IDH1
    Xingkang Wu, Yang Li, Chenchen Han, Shi-Fei Li, Xuemei Qin · 2024 · International Journal of Molecular Sciences
  46. Research advances in branched-chain amino acid metabolism in tumors
    Zheng Li, Sainan Chen, Xiaoyan Wu, Fei Liu, Jing Zhu, Jiayi Chen, Xiaojie Lu, Rui Chi · 2024 · Molecular and Cellular Biochemistry
  47. Multiplexed Data-Independent Acquisition (mDIA) to Profile Extracellular Vesicle Proteomes
    Yi‐Kai Liu, Nathaniel Miller, Marco Hadisurya, Zheng Zhang, W. Andy Tao · 2026 · Molecular & Cellular Proteomics
  48. Insights into DEPTOR regulation from in silico analysis of DEPTOR complexes
    Aik-Hong Teh, Kean-Heng Yeap, Tamao Hisano · 2020 · Journal of Structural Biology
  49. Both Enantiomers of 2-Hydroxyglutarate Modulate the Metabolism of Cultured Human Neuroblastoma Cells
    Eduard Gondáš, Eva Baranovičová, Peter Bystrický, Jakub Šofránko, Andrea Evinová, Matúš Dohál, Zuzana Hatoková, Radovan Murín · 2024 · Neurochemical Research
  50. Multicenter validation of amide proton transfer imaging for the classification of adult-type diffuse gliomas
    Tongling Jiang, Minghao Wu, Junjiao Hu, Hu Guo, Xiaoyue Ma, Yaou Liu, Yi Zhang · 2025 · Magnetic Resonance Imaging
  51. Application of the Hydrophilic Interaction Liquid Chromatography (HILIC-MS) Novel Protocol to Study the Metabolic Heterogeneity of Glioblastoma Cells
    Jakub Šofránko, Eduard Gondáš, Radovan Murín · 2024 · Metabolites
  52. Exploring the effects of ROS on PI3K/AKT/mTOR signalling in pediatric low-grade glioma and therapeutic strategies
    Jayita Das, Nilanjan Adhikari, Ayan Pal, Tanaya Chongder, Samar Dule, Atanu Sarma, Sumit Dutta, Priyanka Gupta, Abhimannu Shome · 2025 · Molecular Biology Reports
  53. Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma
    Priya Choudhry, Corynn Kasap, Bonell Patiño-Escobar, Olivia Gugliemini, Huimin Geng, Vishesh Sarin, Amrik S. Kang, Audrey Kishishita, Sham Rampersaud, Letitia Sarah et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Role of Histone Methylation in Cancer: Pathobiology and Therapeutics
    Devipriya Nagarajan, Sunilgowda Sunnagatta Nagaraja, Shreya Baisakhiya · 2022 · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
  55. Resolving challenges in detection and quantification of D-2-hydroxyglutarate and L-2-hydroxyglutarate via LC/MS
    Tyrone Dowdy, Mioara Larion · 2026 · Methods
  56. Differential metabolomic pathway analysis in Malaysian childhood acute lymphoblastic leukemia patients treated with high-dose methotrexate
    Rizal Husaini Razali, Lay Kek Teh, Mohd Zaki Salleh, Kok Hoi Teh, Hishamshah Mohd Ibrahim · 2024 · Pediatric Hematology Oncology Journal
  57. Implications of Chemokine Heterogenicity in Cancer Metastasis
    Manzoor Ahmad Mir, Sumaya Sumaya, Nusrat Jan · 2023 · Springer eBooks
  58. NOVEL COMPUTATIONAL METHODS FOR CANCER GENOMICS DATA ANALYSIS
    Jinpeng Liu · 2021 · UKnowledge (University of Kentucky)
  59. Cell contractility-induced mechanical stress triggers eIF2α-regulated translation during early adhesion of mesenchymal-like cells
    Alexia Caillier, Mathilde Lavigne, Jonathan Bergeman, Nadine Morin, Félix Rondeau, Juliette Gouhier, Benjamin Trudel, Jean‐Philippe Lambert, Rachid Mazrouï, François Bordeleau et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Role of Histone Methylation in Cancer: Pathobiology & Therapeutics
    Devipriya Nagarajan, Sunilgowda Sunnagatta Nagaraja, Shreya Baisakhiya · 2022 · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
  61. Tumor Biology
    Farshad Nassiri, Laureen D. Hachem, Gelareh Mohammed Zadeh · 2019 · Springer eBooks
  62. Engineering lipid nanoparticles to deliver drug combinations to improve therapeutic efficacy in triple negative breast cancer
    Bumjun Kim · 2018
  63. EIF4A inhibition targets bioenergetic homeostasis in AML and synergizes with cytarabine and venetoclax
    Katie Fooks, Gabriela Galicia-Vázquez, Alejandro Schcolnik‐Cabrera, Victor Gife, Zaynab Nouhi, William W. L. Poon, Vincent Mingyi Luo, Raquel S. Aloyz, Alexandre Orthwein, Laura Hulea et al. · 2022 · Research Square
  64. The Role of RNA Epitranscriptomics and the RNA Fat Mass and Obesity-Associated Demethylase in Triple Negative Breast Cancer
    Emilija Sagaityte, Richard S. Dowd, Kendall Lane, Stephanie L. Graff, Steven A. Toms · 2023 · Advances in Breast Cancer Research
  65. Hydroxysafflor Yellow A ameliorates adenomyosis by improving IDH1-autophagy-EMT
    Xinran Li, zhou Xu, Liwei Wang, Xintong Li, Xuefeng Wu, Xudong Wu, Hao Hong, Yan Shen, Ronghui Du · 2023
  66. idh-1 neomorphic mutation confers sensitivity to vitamin B12 via increased dependency on one-carbon metabolism in Caenorhabditis elegans
    Olga Ponomarova, Alyxandra N. Starbard, Alexandra C. Belfi, Amanda V Anderson, Meera V. Sundaram, Albertha J.M. Walhout · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Concurrent PIK3CA and IDH1 variants in facial infiltrating lipomatosis with intracranial lesions
    Hongrui Chen, Bin Sun, Lizhen Wang, Lei Chang, Yu Zhang, Wei Gao, Yajing Qiu, Hui Chen, Chen Hua, Xiaoxi Lin · 2024 · Genes & Diseases
  68. Metabolomics and racial disparities in bladder cancer carcinogenesis
    Gorrepati Rohith, Swarnendu Mandal · 2024 · Elsevier eBooks
  69. Isocitrate dehydrogenase 1 gene mutations: a case review unveiling its biological impact on disease progression, prognosis and treatment in Chilean patients
    Tomas de Mayo, Benjamín García‐Bloj, Juan Alejandro Godoy, Fernando Sigler Chávez, Ignacio N. Retamal, Fernán Gómez‐Valenzuela, Ian Silva, Matías Muñoz‐Medel, Carolina Sánchez, Felipe Pinto et al. · 2025 · BJR|case reports
  70. An Overview of Analytical Approaches to Cancer Proteogenomics
    Chad J. Creighton · 2025 · Methods in molecular biology
  71. Additional file 1 of EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax
    Katie Fooks, Gabriela Galicia-Vázquez, Victor Gife, Alejandro Schcolnik‐Cabrera, Zaynab Nouhi, William W. L. Poon, Vincent Mingyi Luo, Rys, Ryan N., Raquel S. Aloyz, Alexandre Orthwein et al. · 2023 · Figshare
  72. Additional file 1 of The histone demethylase JMJD2A promotes glioma cell growth via targeting Akt-mTOR signaling
    Li, Min, Cheng, Jingmin, Ma, Yuan, Guo, Heng, Haifeng Shu, Huang, Haidong, Kuang, Yongqin, Yang, Tao · 2020 · Figshare
  73. A metabolic crosstalk between liposarcoma and skeletal muscle sustains tumor growth
    Jaime Prieto Romero · 2020 · theses.fr (ABES)
  74. Characterization of cellular heterogeneity in Diffuse Low Grade Glioma
    Meera Augustus · 2020 · theses.fr (ABES)
  75. The role of the GATOR1 complex in mitochondrial function and quality control
    Hanxiao Zhang · 2025 · theses.fr (ABES)
  76. The Emerging Role of mTOR in Shaping the Cancer Cell Secretome and Plasticity
    Tyler T. Cooper, Ivan Topisirović, Lynne-Marie M Postovit · 2026 · Molecular and Cellular Biology
  77. Biallelic variants in IBA57 with multiple mitochondrial dysfunction syndrome 3
    Yijuan Huang, Chenyu Gou, Yuanqiu Chen, Qihao Pan, Tongtong Chen, Z Zhang, Xiaohong Wang, Si Li, Yufei Han, Weiying Jiang et al. · 2026 · Frontiers in Genetics
  78. The interplay between BECN1-mediated autophagy, metabolism and the cellular response to ionising radiation
    Lingyi Cai, Verena Jendrossek, Johann Matschke, Silvia Vega-Rubín-de-Celis · 2026 · International review of cytology
  79. Metabolic modulation of glioblastoma by dietary intervention: a systematic review
    Maged T Ghoche, Kenji Miki, Fanen Yuan, Megan Mantica, Sameer Agnihotri, Samuel K. McBrayer, Kalil G. Abdullah · 2026 · Journal of Neuro-Oncology
  80. Epigenetic personalized medicine in glioblastoma
    Massimo Romani · 2026 · Handbook of clinical neurology